2. Signaling Pathways
  3. Others
  4. Others

Others

 
Cat. No. Product Name Effect Purity Chemical Structure
  • HY-121219
    (-)-Lupinine
    		≥98.0%
    (-)-Lupinine is a quinolizidine alkaloid.
    (-)-Lupinine
  • HY-P11281A
    GYGGGP(GPP)5GFOGER(GPP)5GPC TFA
    GYGGGP(GPP)5GFOGER(GPP)5GPC TFA is a type I collagen mimic that can bind to integrins and modify hydrogels.
    GYGGGP(GPP)5GFOGER(GPP)5GPC TFA
  • HY-177108
    AP-503
    		99.84%
    AP-503 is a selective GPR133/ADGRD1 agonist with an EC50 of 1.21 nM. AP-503 is used in research on the prevention of muscle-related diseases and vestibular dysfunction.
    AP-503
  • HY-N7698
    Tetra-N-acetylchitotetraose
    Tetra-N-acetylchitotetraose elicits plant defense systems. Tetra-N-acetylchitotetraose is a component of the hpo-chitoo gosacchaπdes (LCOs) secreted from Rhizobia. Tetra-N-acetylchitotetraose is also a substrate for the Rhizobium leguminosarum nodulation protein NodB, a CO deacetylase.
    Tetra-N-acetylchitotetraose
  • HY-137261
    UDP-β-D-glucose disodium
    		99.9%
    UDP-β-D-glucose disodium is a the stereoisomer of UDP-α-D-glucose. UDP-β-D-glucose disodium is an oligosaccharide that can be used to synthesize glycoproteins and glycolipids. UDP-β-D-glucose disodium can be used as a substrate.
    UDP-β-D-glucose disodium
  • HY-B1219
    Pentolinium tartrate
    Pentolinium tartrate is a ganglionic blocking agent. Pentolinium tartrate lowers blood pressure and permits regression of the signs and symptoms associated with severe hypertension.
    Pentolinium tartrate
  • HY-N15720
    HN-saponin F
    		98.45%
    HN-saponin F (Pulsatilla saponin B) is an orally active triterpenoid saponin found in Lonicera macranthoides. HN-saponin F exerts anti-inflammatory activity by regulating inflammation-related pathways (e.g., inhibiting pro-inflammatory factor release). HN-saponin F is promising for research of inflammatory diseases.
    HN-saponin F
  • HY-W014632
    4-Trifluoromethylsalicylic acid
    		Inhibitor 99.93%
    4-Trifluoromethylsalicylic acid (Desacetyl triflusal) is a platelet aggregation inhibitor.
    4-Trifluoromethylsalicylic acid
  • HY-101554
    Guancydine
    		98.0%
    Guancydine (Guancidine) is an antihypertensive agent.
    Guancydine
  • HY-120148A
    SM19712
    		≥99.0%
    SM19712 serves as an inhibitor of the nonpeptide endothelin converting enzyme.
    SM19712
  • HY-B1032R
    Dropropizine (Standard)
    Dropropizine (Standard) is the analytical standard of Dropropizine. This product is intended for research and analytical applications. Dropropizine ((±)-Dropropizine) is a peripheral antitussive agent that acts by inhibiting cough reflex through its action on the peripheral receptors and their afferent conductors.
    Dropropizine (Standard)
  • HY-N7698A
    Penta-N-acetylchitopentaose
    		99.94%
    Penta-N-acetylchitopentaose elicits plant defense systems. Penta-N-acetylchitopentaose is a substrate for the Rhizobium leguminosarum nodulation protein NodL.
    Penta-N-acetylchitopentaose
  • HY-B2177
    Apronal
    		98.0%
    Apronal (Allylisopropylacetylurea, Apronalide) can bu used for the research of neuropsychiatry disorders.
    Apronal
  • HY-101580
    Paliroden
    Paliroden is an orally bioactive neurotrophic, non-peptidic compound that activates synthesis of endogenous neurotrophines, used for treatment of Alzheimer's Disease and Parkinson's.
    Paliroden
  • HY-175200
    DEL-S1
    DEL-S1 is a SLIT2 binder. DEL-S1 significantly impairs SLIT2/ROBO1 complex formation by inducing conformational rearrangements, further inhibits its function with an IC50 of 68.8  μM. DEL-S1 can be used for neural development, immune regulation and cancers like glioblastoma research.
    DEL-S1
  • HY-W190956
    (S,R,S)-AHPC-PEG4-acid
    		98.26%
    (S,R,S)-AHPC-PEG4-acid is a synthetic PROTAC ligand that binds the E3 ligase ligand to the PEG4 arm, thereby enhancing PROTAC drug research and discovery.
    (S,R,S)-AHPC-PEG4-acid
  • HY-116849
    LY 181984
    LY181984 is a compound in a series of orally active diarylsulfonylureas. LY181984 shows antitumor activity.
    LY 181984
  • HY-W276106
    KM02894
    		99.31%
    KM02894 is an inhibitor of glutamate release. Cancer cells release high levels of glutamate, which disrupts normal bone turnover and may lead to cancer-induced bone pain. KM02894 can be used for cancer related research.
    KM02894
  • HY-129415
    Esaprazole
    		98.06%
    Esaprazole (Hexaprazole) is an antiulcer agent that has the effect of promoting the healing of peptic ulcer. Esaprazole can inhibit the secretion of gastric acid and pepsin.
    Esaprazole
  • HY-148528
    SC-VC-PAB-N-Me-L-Ala-Maytansinol
    		98.16%
    SC-VC-PAB-N-Me-L-Ala-Maytansinol (compound B1) can be used to synthesis MCC-Maytansinoid A. SC-VC-PAB-N-Me-L-Ala-Maytansinol can be used as a control compound for the cancer research.
    SC-VC-PAB-N-Me-L-Ala-Maytansinol
Cat. No. Product Name / Synonyms Application Reactivity